Front Line Genomics Magazine Issue 15 – AMP 2017
- Science Round Up
Oxford Nanopore’s long-read, real-time, MinION sequencer is being used by researchers across China.
- Genomics Round Up
- Almost 80% of schizophrenia risk is down to genetics, and what makes a tumour-suppressor protein tick?
- Business Round Up
The FDA has approved a second cancer-killing gene therapy, and a new partnership hopes to grant researchers access to better data and support collaborations.
- AMP 2017
Discover all there is to know about this year’s event.
- Saving Lives in Real-Time
How does genomics revolutionise infectious disease? We have brought together a panel of experts to discuss the possibilities.
- Stepping into Molecular Diagnostics
Marketing Manager, Chinmay Sheth tells us about Bio-Rad Laboratories new product kit.
- Pharmacogenomics: Getting Personal
It’s time to start getting informed and engaged about your own genetic profile.
- What’s Next for Cytogenetics?
Hutton Kearney explores some of the challenges facing cytogeneticists.
- Tackling Disease Surveillance
The study of viruses has never been more vital, find out why.
- Opportunities for Advancements on the Promise of Genomic Medicine
Nazneen Aziz, from Kaiser Permanente tells us why healthcare organisations are vital in helping new discoveries get integrated into the clinic.
- Hunting Structural Variants: Population by Population
Luke Hickey tells us how population and ethnic-group specific efforts are working to catalogue variants, in underrepresented genomic databases.
- Understanding the Genetic Contributors of Disease
We take a look at how the Utah Genome Project is discovering new disease-causing genes to transform healthcare.
- Juggling Responsibility
Find out how AMP President, Federico Monzon manages to juggle his work commitments with family duties.
- Blade Runner 2049
Carl Smith and David Smith return, this time debating whether the anticipated sequel lived up to all of its expectations.
Back issues can be found here.
If you are experiencing any difficulties, please e-mail email@example.com